Christian Taverna - Concepedia

Author

Christian Taverna

Also Known As

C Taverna, C. J. Taverna, C. Taverna, Christian J. Taverna, Christian Taverna, Taverna C., Taverna, Christian, Taverna, Christian 19XX-, Viola Heinzelmann-Schwarz

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

Kantonsspital Münsterlingen University Hospital of Zurich Kantonsspital St. Gallen University of Zurich Triemli Hospital

About

Christian Taverna is an author at Kantonsspital Münsterlingen specializing in medicine, pathology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	376
2	Health Sciences	4	4	236
3	Cell Biology	1	1	19
4	Classical Hematology	1	1	19
5	Exercise Physiology	1	1	131

Christian Taverna

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
Non-Hodgkin Lymphoma and Hodgkin Disease: Coregistered FDG PET and CT at Staging and Restaging—Do We Need Contrast-enhanced CT? Niklaus Schaefer, Thomas F. Hany, Christian Taverna, Radiology	2004	341
Neoadjuvant Chemotherapy Followed by Extrapleural Pneumonectomy in Malignant Pleural Mesothelioma Walter Weder, Peter Kestenholz, Christian Taverna, Journal of Clinical Oncology	2004	243
Effects of an outpatient physical exercise program on hematopoietic stem-cell transplantation recipients: a randomized clinical trial Ruud H. Knols, Eling D. de Bruin, Daniel Uebelhart, Bone Marrow Transplantation Randomized Clinical TrialPhysical ActivityHealth PolicyExercisePhysical Fitness	2010	131
Bone involvement in patients with lymphoma: the role of FDG-PET/CT Niklaus Schaefer, Klaus Strobel, Christian Taverna, European Journal of Nuclear Medicine and Molecular Imaging Bone DiseaseLymphoid NeoplasiaBone ImagingPathologyBone Density	2006	121
Rituximab Purging and/or Maintenance in Patients Undergoing Autologous Transplantation for Relapsed Follicular Lymphoma: A Prospective Randomized Trial From the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation Ruth Pettengell, Norbert Schmitz, Christian Gisselbrecht, Journal of Clinical Oncology	2013	117
Hodgkin Disease: Diagnostic Value of FDG PET/CT after First-Line Therapy—Is Biopsy of FDG-avid Lesions Still Needed? Niklaus Schaefer, Christian Taverna, Klaus Strobel, Radiology	2007	76
Second-line high-dose chemotherapy in patients with mediastinal and retroperitoneal primary non-seminomatous germ cell tumors: the EBMT experience Ugo De Giorgi, T. Demirer, H. Wandt, Annals of Oncology Second-line High-dose ChemotherapyUrologySurgical OncologyGenitourinary CancerMedicine	2004	69
Fusion PET–CT imaging of neurolymphomatosis Andreas Trojan, Martin Jermann, Christian Taverna, Annals of Oncology Positron Emission TomographyNeuro-oncologyMedical ImagingPet-mriBiomedical Imaging	2002	63
Rituximab Maintenance for a Maximum of 5 Years After Single-Agent Rituximab Induction in Follicular Lymphoma: Results of the Randomized Controlled Phase III Trial SAKK 35/03 Christian Taverna, Giovanni Martinelli, Felicitas Hitz, Journal of Clinical Oncology	2015	62
Bortezomib Retreatment in Relapsed Multiple Myeloma – Results from a Retrospective Multicentre Survey in Germany and Switzerland Irena Hrusovsky, B. Emmerich, A. von Rohr, Oncology	2010	45

Page 1